Study success for Pfizer, Novartis drugs

COPD in November 2009, boosting the Swiss drugmaker's ambitions in respiratory medicine, a field currently dominated by GlaxoSmithKline, AstraZeneca and Pfizer. The US Food and Drug Administration is due to rule whether it will back the drug in July...